Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-10 Sale | 2022-01-11 6:54 pm | Catalent Inc. | CTLT | Flynn Karen Chief Commercial Officer | 2,472 | $116.64 | $288,334 | 33,223 (Direct) | View |
| 2021-01-11 Sale | 2021-01-11 7:12 pm | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 2,478 | $112.3 | $278,279 | 34,544 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:44 pm | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 99 | $104.42 | $10,338 | 37,022 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 4:09 pm | 2024-12-31 2034-01-02 | Quanterix Corp | QTRX | Flynn Karen Director | 9,359 | $0 | 32,817 (Direct) | View |
| 2023-10-27 Option Award | 2023-10-31 5:00 pm | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Director | 6,993 | $0 | 24,339 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:03 pm | N/A N/A | Quanterix Corp | QTRX | Flynn Karen Director | 918 | $12.86 | 35,582 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:03 pm | 2023-12-31 2033-01-03 | Quanterix Corp | QTRX | Flynn Karen Director | 20,207 | $0 | 35,582 (Direct) | View |
| 2022-10-27 Option Award | 2022-10-31 4:49 pm | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Director | 4,149 | $0 | 17,346 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 4:04 pm | N/A N/A | Quanterix Corp | QTRX | Flynn Karen Director | 1,066 | $10.48 | 14,457 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-19 2:31 pm | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Director | 245 | $0 | 13,197 (Direct) | View |
Ownership | 2022-09-19 2:15 pm | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Director | 0 | $0 | 18,442 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:07 pm | N/A N/A | Quanterix Corp | QTRX | Flynn Karen Director | 164 | $16.79 | 13,391 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-14 12:09 pm | N/A 2032-06-06 | Quanterix Corp | QTRX | Flynn Karen Director | 33,068 | $0 | 33,068 (Direct) | View |
| 2021-07-26 Option Award | 2021-07-28 4:26 pm | N/A 2031-07-26 | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 7,104 | $0 | 41,648 (Direct) | View |
| 2020-07-30 Option Award | 2020-08-03 09:03 am | N/A 2030-07-30 | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 9,481 | $0 | 45,126 (Direct) | View |
| 2020-04-09 Option Award | 2020-04-13 12:19 pm | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 359 | $56.46 | 35,645 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-09 11:22 am | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 35,286 | $0 | 35,286 (Direct) | View |
Ownership | 2020-01-09 11:13 am | N/A N/A | Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO | 0 | $0 | 0 (Direct) | View |
| 2019-12-05 Option Award | 2019-12-16 7:47 pm | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 11,071 | $0 | 39,283 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-13 10:43 am | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Flynn Karen Director | 18,843 | $0 | 39,100 (Direct) | View |